MedPath

MEDSENIC

🇫🇷France
Ownership
-
Employees
-
Market Cap
-
Website

Treatment of Chronic Graft Versus Host Disease With Arsenic Trioxide

Phase 2
Completed
Conditions
Immune System Diseases
Chronic Graft-Versus-Host Disease
Interventions
First Posted Date
2016-11-17
Last Posted Date
2022-05-09
Lead Sponsor
Medsenic
Target Recruit Count
21
Registration Number
NCT02966301
© Copyright 2025. All Rights Reserved by MedPath